<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Economics</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Economics</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Экономика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-2329</issn><issn publication-format="electronic">2408-8986</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">32145</article-id><article-id pub-id-type="doi">10.22363/2313-2329-2022-30-3-304-316</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ECONOMIC AND SOCIAL TRENDS: POST-COVID-19 DEVELOPMENT</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКОНОМИЧЕСКИЕ И СОЦИАЛьНЫЕ ТРЕНДЫ: РАЗВИТИЕ МИРА ПОСЛЕ COVID-19</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The COVID-19 pandemic and China’s health care system: Current impact and long-term prospects</article-title><trans-title-group xml:lang="ru"><trans-title>Пандемия COVID-19 и система здравоохранения Китая: текущее воздействие и долгосрочные перспективы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0672-8097</contrib-id><name-alternatives><name xml:lang="en"><surname>Gubina</surname><given-names>Maryana A.</given-names></name><name xml:lang="ru"><surname>Губина</surname><given-names>Марьяна Андреевна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD in Economics, Associate Professor, Department of World Economy, Faculty of Economics</p></bio><bio xml:lang="ru"><p>кандидат экономических наук, доцент кафедры мировой экономики экономического факультета</p></bio><email>m.gubina@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Terenteva</surname><given-names>Daria V.</given-names></name><name xml:lang="ru"><surname>Терентьева</surname><given-names>Дарья Васильевна</given-names></name></name-alternatives><bio xml:lang="en">4th year undergraduate student of the “Economics (with advanced study of Chinese economy and Chinese language)”, Faculty of Economics</bio><bio xml:lang="ru">бакалавриант 4-го курса ОП «Экономика (с углубленным изучением экономики Китая и китайского языка)», экономический факультет</bio><email>dasha.terentyeva.2000@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Saint-Petersburg State University</institution></aff><aff><institution xml:lang="ru">Санкт-Петербургский государственный университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-10-03" publication-format="electronic"><day>03</day><month>10</month><year>2022</year></pub-date><volume>30</volume><issue>3</issue><issue-title xml:lang="en">Global Economy: Actual Problems</issue-title><issue-title xml:lang="ru">Глобальная экономика: актуальные проблемы</issue-title><fpage>304</fpage><lpage>316</lpage><history><date date-type="received" iso-8601-date="2022-10-03"><day>03</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Gubina M.A., Terenteva D.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Губина М.А., Терентьева Д.В.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Gubina M.A., Terenteva D.V.</copyright-holder><copyright-holder xml:lang="ru">Губина М.А., Терентьева Д.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/economics/article/view/32145">https://journals.rudn.ru/economics/article/view/32145</self-uri><abstract xml:lang="en"><p style="text-align: justify;">The COVID-19 pandemic is a real crisis for global and national economies and health systems around the world. It has already taken many lives, and many people are still complaining about the consequences of being infected with this virus. The pandemic has demonstrated the weaknesses of national health systems - the unpreparedness for emergencies and their rapid prevention. These problems were expressed in the inability to detect the threat early, overloaded medical facilities, acute shortage of personal protective equipment and personnel. Nevertheless, the success of China in the fight against the virus, expressed in effective containment tactics, as well as in the reduction of COVID-19 incidence in the country, cannot be overlooked. The purpose of this article is to analyze the impact of the COVID-19 pandemic on the PRC health care system and its medical reforms. Since 2012, large-scale reforms have been carried out in China to achieve a “basic healthcare system with Chinese features.” Universal health coverage is extremely important because it helps, in addition to equality, to achieve financial well-being for citizens and economic development for the country. The following results were obtained: despite the abundance of negative consequences for the economy and health of citizens, the pandemic contributed to the successful implementation of information technologies in health care; had a positive impact on the relationship between Chinese doctors and patients (which has been in deep crisis for a long time); became the reason for China’s leadership in the world vaccine market for the first time in history. Thus, we can conclude about the dual impact of COVID-19 on the industry. The pandemic has already led to a number of significant changes, and now another wave of infections is hampering reform goals, including the Healthy China 2030 program, which will affect the health and wellbeing of 1.4 billion Chinese, but making long-term predictions in an ever-changing environment is impossible. As practice has shown, initial success in combating the disease is not enough: plans to recover from one health crisis have been replaced by yet another plan to fight the new wave of COVID-19.</p></abstract><trans-abstract xml:lang="ru"><p style="text-align: justify;">Пандемия COVID-19 - настоящее испытание, кризис для глобальной и национальных экономик и систем здравоохранения всех стран мира. Она уже унесла множество жизней, а многие люди до сих пор переживают последствия заражения данным вирусом. Пандемия продемонстрировала слабые места национальных систем здравоохранения - неготовность к чрезвычайным ситуациям и их быстрому предотвращению. Эти проблемы выражались в неспособности раннего обнаружения угрозы, перегруженности медицинских учреждений, острой нехватке средств индивидуальной защиты и персонала. Тем не менее нельзя не отметить успех КНР в борьбе с COVID-19, выраженный в эффективной тактике сдерживания, а также в снижении заболеваемости вирусом на территории страны. Целью исследования является анализ влияния пандемии COVID-19 на систему здравоохранения КНР и проведение медицинских реформ. Начиная с 2012 г. в Китае проводятся масштабные реформы для достижения «базовой системы здравоохранения с китайскими особенностями». Всеобщий охват медицинскими услугами исключительно важен, поскольку помогает, помимо равенства, достичь финансового благополучия гражданам и экономического развития - стране. Исследование выявило, что, несмотря на обилие негативных последствий для экономики и здоровья граждан, пандемия способствовала успешному внедрению информационных технологий в здравоохранение; оказала благотворное влияние на отношения китайских врачей и пациентов (которые уже на протяжении долгого времени находятся в состоянии глубокого кризиса); стала причиной лидерства Китая на мировом рынке вакцин впервые за всю историю. Таким образом, мы можем сделать выводы о двояком влиянии COVID-19 на отрасль. Пандемия уже привела к ряду значительных изменений, и сейчас очередная волна заражений препятствует реализации целей реформ, в том числе программы «Здоровый Китай - 2030», что скажется на здоровье и благополучии 1,4 миллиарда китайцев. Давать долгосрочные прогнозы в условиях постоянно меняющейся ситуации невозможно. Как показала практика, первоначального успеха в борьбе с заболеванием недостаточно: планы восстановления после одного кризиса в области здравоохранения сменились очередными планами борьбы с новой волной COVID-19.</p></trans-abstract><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>health care system</kwd><kwd>People’s Republic of China</kwd><kwd>pandemic</kwd><kwd>COVID-19</kwd><kwd>online hospitals</kwd><kwd>vaccination</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>система здравоохранения</kwd><kwd>Китайская Народная Республика</kwd><kwd>пандемия</kwd><kwd>онлайн-больницы</kwd><kwd>вакцинация</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Du, Z., Xu, X., Wu, Y., Wang, L., Cowling, B.J., &amp; Meyers, L.A. (2020). Serial interval of COVID-19 among publicly reported confirmed cases. Emerging infectious diseases, 26(6), 1341. https://doi.org/10.3201%2Feid2606.200357</mixed-citation><mixed-citation xml:lang="ru">Перхов В.И., Песенникова Е.В. Особенности реакции систем здравоохранения отдельных стран на предсказанную пандемию COVID 19 // Медицина и организация здравоохранения. 2020. Т. 5, № 3. С. 4-12</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Gao, B., &amp; Dong, J. (2020). Does the impact of COVID-19 improve the doctor-patient relationship in China? The American Journal of the Medical Sciences, 360(3). https://doi.org/10.1016/j.amjms.2020.05.039</mixed-citation><mixed-citation xml:lang="ru">Решетникова М.С. Китайский опыт развития искусственного интеллекта: промышленная цифровизация // Вестник Российского университета дружбы народов. Серия: Экономика. 2020. Т. 28, no. 3. С. 536-546. http://dx.doi.org/10.22363/2313-2329-2020-28-3536-546</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Hu, Y., &amp; Chen, S. (2021). What can we learn from COVID-19 vaccine R&amp;D in China? A discussion from a public policy perspective. Journal of Travel Medicine, 28(4). https://doi.org/10.1093/jtm/taab026</mixed-citation><mixed-citation xml:lang="ru">Du Z. et al. Serial interval of COVID-19 among publicly reported confirmed cases // Emerging infectious diseases. 2020. Vol. 26, no. 6. P. 1341. https://doi.org/10.3201/eid2606.200357</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Huang, Y. (2020). Xi Jinping Won the Coronavirus Crisis. Foreign Affairs, 13.</mixed-citation><mixed-citation xml:lang="ru">Gao B., Dong J. Does the impact of COVID-19 improve the doctor-patient relationship in China? // The American Journal of the Medical Sciences. 2020. Vol. 360, no. 3.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Jiang, X., Xie, H., Tang, R., Du, Y., Li, T., Gao, J., &amp; Xie, G. (2021). Characteristics of online health care services from China’s largest online medical platform: cross-sectional survey study. Journal of Medical Internet Research, 23(4), e25817. https://doi.org/10.2196/25817</mixed-citation><mixed-citation xml:lang="ru">Hu Y., Chen S. What can we learn from COVID-19 vaccine R&amp;D in China? A discussion from a public policy perspective // Journal of Travel Medicine. 2021. Vol. 28, no. 4.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Leung, K., Wu, J.T., Liu, D., &amp; Leung, G.M. (2020). First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. The Lancet, 395(10233), 1382–1393. https://doi.org/10.1016/S0140-6736(20)30746-7</mixed-citation><mixed-citation xml:lang="ru">Huang Y. Xi Jinping Won the Coronavirus Crisis // Foreign Affairs. 2020. Vol. 13.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Li, L., Liu, G., Xu, W., Zhang, Y., &amp; He, M. (2020). Effects of internet hospital consultations on psychological burdens and disease knowledge during the early outbreak of COVID-19 in China: Cross-sectional survey study. Journal of Medical Internet Research, 22(8), e19551. https://doi.org/10.2196/19551</mixed-citation><mixed-citation xml:lang="ru">Jiang X. et al. Characteristics of online health care services from China’s largest online medical platform: cross-sectional survey study // Journal of Medical Internet Research. 2021. Vol. 23, no. 4. P. e25817.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Liu, Y., Eggo, R.M., &amp; Kucharski, A.J. (2020). Secondary attack rate and superspreading events for SARS-CoV-2. The Lancet, 395(10227), e47. https://doi.org/10.1016/S0140-6736(20)30462-1</mixed-citation><mixed-citation xml:lang="ru">Leung K. et al. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment // The Lancet. 2020. Vol. 395, no. 10233. P. 1382-1393</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Milcent, C. (2016). Evolution of the health system: Inefficiency, violence, and digital healthcare. China Perspectives, 4, 39–50. https://doi.org/10.4000/chinaperspectives.7112</mixed-citation><mixed-citation xml:lang="ru">Li L. et al. Effects of internet hospital consultations on psychological burdens and disease knowledge during the early outbreak of COVID-19 in China: Cross-sectional survey study // Journal of Medical Internet Research. 2020. Vol. 22, no. 8. P. e19551</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Milcent, C. (2018). Healthcare reform in China: From violence to digital healthcare. Springer. https://doi.org/10.1007/978-3-319-69736-9</mixed-citation><mixed-citation xml:lang="ru">Liu Y., Eggo R.M., Kucharski A.J. Secondary attack rate and superspreading events for SARSCoV-2 // The Lancet. 2020. Vol. 395, no. 10227. P. e47.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Perkhov, V.I., &amp; Pesennikova, E.V. (2020). Variety of forms of reaction of health care systems of particular countries to the predicted COVID-19 pandemic. Medicine and Health Care Organization, 5(3), 4–12.</mixed-citation><mixed-citation xml:lang="ru">Milcent C. Evolution of the Health System. Inefficiency, Violence, and Digital Healthcare // China perspectives. 2016. Vol. 2016, no. 2016/4. P. 39-50.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Reshetnikova, M.S. (2020). China’s AI experience: Industrial digitalization. RUDN Journal of Economics, 28(3), 536–546. (In Russ.) http://dx.doi.org/10.22363/2313-2329-2020-283-536-546</mixed-citation><mixed-citation xml:lang="ru">Milcent C. Healthcare reform in China: From violence to digital healthcare. Springer, 2018.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Sang, T., Zhou, H., Li, M., Li, W., Shi, H., Chen, H., &amp; Zhou, H. (2020). Investigation of the differences between the medical personnel’s and general population’s view on the doctorpatient relationship in China by a cross-sectional survey. Globalization and health, 16(1), 1–12. https://doi.org/10.1186/s12992-020-00625-9</mixed-citation><mixed-citation xml:lang="ru">Sang T. et al. Investigation of the differences between the medical personnel’s and general population’s view on the doctor-patient relationship in China by a cross-sectional survey // Globalization and health. 2020. Vol. 16, no. 1. P. 1-12</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Wu, J.T., Leung, K., &amp; Leung, G.M. (2020). Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet, 395(10225), 689–697. https://doi.org/10.1016/S01406736(20)30260-9</mixed-citation><mixed-citation xml:lang="ru">Wu J.T. et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China // Nature medicine. 2020. Vol. 26, no. 4. P. 506-510</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Wu, J.T., Leung, K., Bushman, M., Kishore, N., Niehus, R., de Salazar, P. M ., &amp; Leung, G.M. (2020). Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature medicine, 26(4), 506–510. https://doi.org/10.1038/s41591-020-0822-7</mixed-citation><mixed-citation xml:lang="ru">Wu J.T., Leung K., Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study // The Lancet. 2020. Vol. 395, no. 10225. P. 689-697</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Xu, X. et al. (2021). Assessment of internet hospitals in China during the COVID-19 pandemic: National cross-sectional data analysis study. Journal of medical Internet research, 23(1). https://doi.org/10.2196/21825</mixed-citation><mixed-citation xml:lang="ru">Xu X. et al. Assessment of internet hospitals in China during the COVID-19 pandemic: National cross-sectional data analysis study // Journal of medical Internet research. 2021. Vol. 23, no. 1.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang, J., Yang, H., Yang, M., &amp; Tan, H. (2022). The role of vaccines in COVID-19 control strategies in Singapore and China. Health Policy and Technology, 100620. https://doi.org/10.1016/j.hlpt.2022.100620</mixed-citation><mixed-citation xml:lang="ru">Zhang J. et al. The role of vaccines in COVID-19 control strategies in Singapore and China // Health Policy and Technology. 2022. P. 100620.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Zhou, M., Zhao, L., Campy, K.S., &amp; Wang, S. (2017). Changing of anihC׳s health policy and Doctor–Patient relationship: 1949–2016. Health policy and technology, 6, 358–367.</mixed-citation><mixed-citation xml:lang="ru">Zhou M. et al. Changing of anihC׳ s health policy and Doctor-Patient relationship: 1949-2016 // Health Policy and Technology. 2017. Vol. 6, no. 3.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Zhou, Y., Chen, S., Liao, Y., Wu, Q., Ma, Y., Wang, D., Wang, X., Li, M., Wang, Y., Wang, Y., Liu, Y., Liu, T. and Yang, WFZ. (2021). General Perception of Doctor–Patient Relationship From Patients During the COVID-19 Pandemic in China: A Cross-Sectional Study. Front. Public Health, 9, 646486. https://10.3389/fpubh.2021.646486</mixed-citation><mixed-citation xml:lang="ru">Zhou Y. et al. Doctor-patient relationship improved during COVID-19 pandemic, but weakness remains // BMC family practice. 2021. Vol. 22, no. 1.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Zhou, Y., Ma, Y., Yang, W.F.Z., Wu, Q., Wang, Q., Wang, D., &amp; Wu, X. (2021). Doctor-patient relationship improved during COVID-19 pandemic, but weakness remains. BMC family practice, 22(1). https://doi.org/10.1186/s12875-021-01600-y</mixed-citation><mixed-citation xml:lang="ru">Zhou Y. et al. General perception of doctor-patient relationship from patients during the COVID-19 pandemic in China: a cross-sectional study // Frontiers in Public Health. 2021. Vol. 9.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Zhu, F.C., Li, Y.H., Guan, X.H., Hou, L.H., Wang, W.J., Li, J.X., &amp; Chen, W. (2020). Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet, 395(10240). https://doi.org/10.1016/s0140-6736(20)31208-3</mixed-citation><mixed-citation xml:lang="ru">Zhu F. et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial // The Lancet. 2020. Vol. 395, no. 10240</mixed-citation></citation-alternatives></ref></ref-list></back></article>
